“…An inhibition of the MMP-9 pathway was described for both minocycline and doxycycline [135,136]. Minocycline has been shown to be neuroprotective in several adult animal models of neurological disorders [137,138,139,140,141,142,143,144]. Similarly, minocycline has been reported to be neuroprotective in developing brain damage models such as hypoxia-ischemia in neonatal or juvenile rats [145,146,147,148,149,150] and excitotoxic perinatal brain damage in mice [69].…”